Business
PDMR Dealing and ESOT Share Purchase
Cellbxhealth plc announced that Executive Chairman Jan Groen and Chief Executive Officer Peter Collins each purchased 5,000,000 ordinary shares at 1.0 pence per share, and Finance Director Sinead Armstrong acquired 2,500,000 ordinary shares at the same price, following an oversubscribed placing. Additionally, the trustee of the ANGLE Employee Share Ownership Trust purchased 2,886,742 ordinary shares at 1.1p each, which will be held for employee benefit. Following these transactions, Dr. Groen and Mr. Collins hold approximately 0.4% of the company's issued share capital, and Mrs. Armstrong holds approximately 0.2%, while the ESOT will hold 3,000,000 shares, representing 0.3%. Disclaimer*
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n\nCELLBXHEALTH plc (\"the Company\")\n\nDIRECTOR/PDMR SHAREHOLDING AND ESOT SHARE PURCHASE\nGuildford, UK - 19 December 2025 - CELLBXHEALTH plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology, announces that, following the Oversubscribed Placing and Subscription announced on the 25 November 2025, Executive Chairman, Jan Groen and Chief Executive Officer Peter Collins each acquired 5,000,000 Ordinary Shares in the Company. In addition, Sinead Armstrong, Finance Director acquired 2,500,000 Ordinary Shares in the Company. All shares were purchased at a price of 1.0 pence, being the Placing Price.\nFollowing the transaction, Dr Groen's and Mr Collins' aggregate direct and indirect ultimate beneficial interest in the Company's Ordinary Shares is 5,000,000 representing approximately 0.4% of the Company's currently issued share capital, Mrs Armstrong's aggregate direct and indirect ultimate beneficial interest in the Company's Ordinary Shares is 2,596,056 representing approximately 0.2% of the Company's currently issued share capital.\nEmployee Share Ownership Trust Share Purchase\nFurthermore, the Company announces that Zedra Trust Company (Guernsey) Ltd, acting as trustee of the ANGLE Employee Share Ownership Trust (the \"ESOT\"), purchased, earlier today, a total of 2,886,742 ordinary shares in the Company at a price of 1.1p each.\n The shares will be held in the ESOT, which is a discretionary trust for the benefit of the Company's employees and will ultimately be used to satisfy share awards and options granted under the Company's various share incentive arrangements.\nThe ESOT may be used to assist in meeting the obligations under employee remuneration schemes with Executive Directors and Persons Discharging Managerial Responsibility of the Company, together with other employees, as potential beneficiaries and are therefore treated as having an interest in some of those shares and the dealings thereof.\n Immediately following settlement of the above transaction, the ESOT will hold 3,000,000 ordinary shares (\"ESOT Shares\") representing 0.3% of the Company's issued share capital.\n The Company's issued share capital as at 19 December 2025 consists of 1,139,402,658 ordinary shares of 0....